The Minneapolis / St. Paul Business Journal is reporting that Aum Cardiovascular, a South Northfield, Minnesota firm, received regulatory approval to introduce its CADence System to the European market. The device may turn out to be an alternative screening tool to nuclear stress testing for detecting coronary artery blockages.
In a sense it is an electronic stethoscope, applied to the chest by a physician to record sounds arising from beneath. Turbulence within the coronary arteries produces a distinct audio signal that can be identified using a proprietary algorithm built into the device. The CADence System is indicated for patients that have chest pains in addition to at least two other coronary artery disease risk factors such as obesity and hypertension. It’s not suitable for patients that have undergone procedures such as bypass grafts and coronary stenting, as well as those with certain conditions, which can confuse the algorithm and lead to false negatives and positives.
The device is yet to receive FDA’s regulatory green light and is planned for release in Europe toward the end of this year.
Link: AUM Cardiovascular…